2023 Recommended Immunization Schedules
Immunization schedules for children, preteens, teens, adults and travelers.
March 9, 2023
Immunization schedules for children, preteens, teens, adults and travelers.
3 COVID-19 vaccines are authorized in the United States: two messenger ribonucleic acid (mRNA) vaccines (Pfizer-BioNTech and Moderna) and one viral vector vaccine (J&J).
Conclusion Influenza vaccines reduce the risk of influenza infection, which causes Guillain-Barré Syndrome (GBS). Thus, influenza vaccines prevent GBS by protecting against natural influenza infection.
Conclusion Influenza vaccines do not cause multiple sclerosis (MS). Other vaccines currently routinely recommended to the general population in the U.S.* have not been shown to cause MS. Epidemiological
Recommendations from the Advisory Committee on Immunization Practices (ACIP) Infants All infants without contraindications should receive the conjugate Hib vaccine series; either as 3 doses
Advisory Committee on Immunization Practices (ACIP) Recommendations Infants All infants without contraindications should receive two doses of hepatitis A vaccine (trade names: Havrix®, Vaqta®) between
ACIP Recs | Disease | Vaccine | References | VIS | WHO modules Advisory Committee on Immunization Practices (ACIP) Recommendations Infants All medically stable infants weighing ≥2,000 grams without contraindications should receive the first dose
ACIP Recs | Disease | Vaccine | References | VIS | WHO modules Advisory Committee on Immunization Practices (ACIP) Recommendations Adolescents and Adults All males and females without contraindications ages 11-12 years should receive two
ACIP Recs | Disease | Vaccine | References | VIS live | VIS inactivated Advisory Committee on Immunization Practices (ACIP) Recommendations All Age Groups All persons without contraindications who are at least 6 months of
ACIP Recs | Disease | Vaccine | References | VIS | WHO modules Advisory Committee on Immunization Practices (ACIP) Recommendations Infants and Children• All children without contraindications should receive two doses of measles-mumps-rubella combination vaccine
ACIP Recs | Disease | Vaccine | References | VIS Conjugate | VIS Polysaccharide | WHO modules Advisory Committee on Immunization Practices (ACIP) Recommendations InfantsAll infants without contraindications should receive four doses of 13-valent pneumococcal conjugate vaccine
ACIP Recs | Disease | Vaccine | References | VIS | WHO modules Advisory Committee on Immunization Practices (ACIP) Recommendations Infants and Children• All infants without contraindications should receive 3 doses of inactivated polio vaccine (abbreviation:
ACIP Recs | Disease | Vaccine | Sources & References | VIS (DTaP) VIS(Tdap) VIS(Td) | WHO modules Advisory Committee on Immunization Practices (ACIP) Recommendations Infants and Children• All infants without contraindications should receive three doses of
ACIP Recs | Disease | Vaccine | References | VIS | WHO modules Advisory Committee on Immunization Practices (ACIP) Recommendations Infants and Children • All children without contraindications should receive two doses of varicella vaccine
Vaccine Information Statements: VISs are sheets developed by the US CDC that detail benefits and risks of a vaccine. Before a dose of vaccine is
Institute for Vaccine Safety
Johns Hopkins Bloomberg School of Public Health
615 N Wolfe Street
Baltimore, MD 21205
USA
All rights reserved.
© 2022 Institute for Vaccine Safety
This website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Member since 2006